Eric Wang

Eric Wang is the Co-Founder of Kate Therapeutics and currently serves as an Associate Professor at the University of Florida. Prior to this, Eric was a Principal Investigator at the Koch Institute for Integrative Cancer Research at MIT. Eric holds a Ph.D. in Bioinformatics and Integrative Genomics from the Harvard-MIT Division of Health Sciences and Technology.